Towards Healthcare
Gene Vector Market to Grow at 21% CAGR till 2035

Gene Vector Market Expands Rapidly with Global Biotech Boom

Based on market forecasts, the global gene vector market, projected at USD 9.61 billion in 2025, is expected to reach USD 64.38 billion by 2035, growing at a CAGR of 21% over the forecast period. The gene vector market is growing due to rising demand for gene and cell therapy. North America’s dominance can be attributed to the rising demand for personalized medicine.

Content

  • Last Updated: 04 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The gene vector market in 2026 is valued at USD 11.64 billion and is projected to climb to USD 64.38 billion by 2035, with a CAGR of 21% over the forecast period.

North America is currently leading the gene vector market share by 42% due to a strong presence of the biotechnology industry.

The gene vector market comprises five segments type, application, form, end-user industry, and region.

Some key players include Lonza, Merck KGaA, Thermo Fisher Scientific, Catalent, Novasep, VGXI, etc.

The most widely used vectors are viruses, yeast cells, and plasmids, which are circular DNA molecules derived from bacteria.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions